Literature DB >> 12203877

Cytohistologic correlations of 24 malignant peripheral nerve sheath tumor (MPNST) in 17 patients: the Institut Curie experience.

Jerzy Klijanienko1, Jean-Michel Caillaud, Réal Lagacé, Philippe Vielh.   

Abstract

Cytomorphological patterns of malignant peripheral nerve sheath tumor (MPNST) are insufficiently documented in the literature. Cytological and histological specimens in 24 tumors in 17 patients were correlated. The review of the original cytology reports showed that four (16.6%) tumors were correctly diagnosed, eight (33.3%) were diagnosed as sarcoma not otherwise specified, four (16.7%) as fibrosarcoma, three (12.5%) as synovial sarcoma, three (12.5%) as leiomyosarcoma, and one (4.2%) case each as malignant fibrous histiocytoma and rhabdomyosarcoma. At the review tumors were histologically reclassified as well-differentiated MPNST in 11 (45.9%) cases, anaplastic MPNST in 11 (45.9%) cases, and epithelioid MPNST and malignant Triton tumor in one (4.2%) case each. Cytologically, well-differentiated MPNST were composed of polymorphous oval to round cells, small spindle-shaped cells with wavy and comma-like naked nuclei, and a fibrillary, delicate stroma. Anaplastic MPNST, moreover, were composed of anaplastic giant and polymorphous cells. The malignant Triton tumor was composed of oval to round rhabdomyoblastic cells with eccentric nuclei and the epithelioid MPNST of polymorphous and round, epithelial-like cells. The cytological diagnosis of MPNST may be difficult, especially in anaplastic tumors. The correlation between the cytological features and the clinical information--origin of the tumor from a nerve trunk, a preexisting neurofibroma, patients with known history of neurofibromatosis 1--could be indicative of an MPNST diagnosis. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2002        PMID: 12203877     DOI: 10.1002/dc.10152

Source DB:  PubMed          Journal:  Diagn Cytopathol        ISSN: 1097-0339            Impact factor:   1.582


  8 in total

Review 1.  [Cytologic diagnosis of sarcoma].

Authors:  B Bode-Lesniewska
Journal:  Pathologe       Date:  2011-02       Impact factor: 1.011

2.  Accuracy and complications of CT-guided core needle biopsy of peripheral nerve sheath tumours.

Authors:  Marcus Pianta; Eric Chock; Stephen Schlicht; David McCombe
Journal:  Skeletal Radiol       Date:  2015-06-16       Impact factor: 2.199

3.  Malignant peripheral nerve sheath tumor (MPNST) in the spine: a retrospective analysis of clinical and molecular prognostic factors.

Authors:  Ting Wang; Huabin Yin; Shuai Han; Xinhai Yang; Jing Wang; Quan Huang; Wangjun Yan; Wang Zhou; Jianru Xiao
Journal:  J Neurooncol       Date:  2015-01-20       Impact factor: 4.130

4.  Malignant peripheral nerve sheath tumor arising from the greater omentum: case report.

Authors:  Masashi Miguchi; Yuji Takakura; Hiroyuki Egi; Takao Hinoi; Tomohiro Adachi; Yasuo Kawaguchi; Manabu Shinomura; Masakazu Tokunaga; Masazumi Okajima; Hideki Ohdan
Journal:  World J Surg Oncol       Date:  2011-03-21       Impact factor: 2.754

5.  Metastatic Epithelioid Malignant Peripheral Nerve Sheath Tumor in a Known Case of Neurofibromatosis-1, Cytomorphological Appearance, and Critical Analysis of Immunohistochemistry.

Authors:  Rakesh Kumar Gupta; Ravindra Kumar Saran; Deepak Ghuliani; Lalit Garg; Abhijit Das
Journal:  Indian J Med Paediatr Oncol       Date:  2017 Jul-Sep

6.  [Cytologic diagnosis of soft tissue tumors].

Authors:  B Bode-Lesniewska
Journal:  Pathologe       Date:  2007-09       Impact factor: 0.973

7.  Malignant peripheral nerve sheath tumor of the small bowel: an unusual presentation with fatal outcome.

Authors:  Amina Mohtaram; Siham Mesmoudi; Hind M'rabti; Amal Rami; Rachida Latib; Zakia Bernoussi; Imane Aaribi; Meryam Ben Ameur El Youbi; Hassan Errihani
Journal:  Case Rep Oncol Med       Date:  2013-08-28

Review 8.  Mediastinal sarcomas: experience using fine needle aspiration cytopathology.

Authors:  Abberly A Lott-Limbach; Paul E Wakely
Journal:  Mediastinum       Date:  2020-06-30
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.